Shares of Kenvue, the consumer-health spinoff of Johnson & Johnson, tumbled 7.1% to a record low of $17.03 on Monday with the selloff coming ahead of US President Donald Trump’s planned announcement that use of Tylenol — Kenvue’s top-selling pain reliever — during pregnancy could contribute to autism risk, according…
Jimmy Kimmel’s late-night return is officially set for Tuesday, the end of a suspenseful six-day stretch that saw the…
Turkey is about to make a big investment in both its sky and defense forces.President Recep Tayyip Erdogan is…
China’s export sector has withstood five months of record-high US tariffs, pushing the country toward a projected $1.2 trillion…
Shares in Orsted surged 9% on Tuesday after a US federal court on Monday allowed the Danish energy company…
Shares in ASM International fell on Tuesday after the Dutch supplier of semiconductor-manufacturing equipment revised its full-year forecast, citing…
The United States has prided itself on being the magnet for the world’s brightest talent. The “American Dream” was…
Germany’s private sector registered its fastest expansion in 16 months in September, driven by a rebound in services that…